The University of Texas MD Anderson and Ipsen, a global biopharmaceutical group, today announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by researchers in MD Anderson’s Institute for Applied Cancer Science (IACS).
Obese children who consume at least two servings of any type of cow’s milk daily are more likely to have lower fasting insulin, indicating better blood sugar control, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex (TSC), doctors at The University of Texas Health Science Center at Houston (UTHealth) reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.
A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival (OS) in patients with stage I, II or III colorectal cancer (CRC). Published in the Journal of the American Medical Association, the study is the largest of surveillance intensity in CRC ever conducted.
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.
In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.
Everyone enjoys spending the summer months in the great outdoors but you have to do it responsibly or injury can occur, say doctors with UT Physicians, the clinical practice of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth.)
A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.
Anesthesiologist Vivian Porche, M.D., could be considered the Texas Medical Center’s very own Mary Poppins and now her daughter Bobbi is following in her high-flying footsteps.
Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who’ve had too much exposure to the glare of electronic screens.
A child obesity expert from the Michael & Susan Dell Center for Healthy Living at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health in Austin was called upon to help lead a groundbreaking project to involve and empower adolescents in the fight against obesity in Europe.
The advances in the treatment of Parkinson’s disease that are helping retired endodontist William Gervasio, D.D.S., and others with this neurodegenerative disorder are the focus of a free public forum at 10:30 a.m. Saturday, May 12, at The University of Texas Health Science Center at Houston (UTHealth) in the Texas Medical Center.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center. The preclinical study suggests that mutations in ARID1a could be beneficial in predicting immunotherapy success.
Does your child dream of making the team next year at school? While the fall semester is months away, now’s the time to schedule a sports physical, according to experts at The University of Texas Health Science Center at Houston (UTHealth).
The University of Texas MD Anderson Cancer Center and Spectrum Pharmaceuticals have signed a licensing agreement that covers discoveries by MD Anderson researchers about the company’s drug poziotinib, a targeted therapy for lung cancer.
When it comes to the examination room at your health care clinic, you might think that avoiding catching the flu or other more deadly viruses is out of your hands, so to speak. But infectious disease experts at The University of Texas Health Science Center at Houston (UTHealth), who just published a practical guide for infectious disease control in clinics, reveal how we can all help make a difference in infection control.
If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study led by The University of Texas MD Anderson Cancer Center has shed light on why proteins, the seedlings that serve as the incubator for many cancers, can vary from cancer to cancer and even patient to patient, a discovery that adds to a growing base of knowledge important for developing more effective precision therapies.
Finding out if varicose veins warrant medical attention can be done in the comfort of your home, thanks to a service provided by UT Physicians, the clinical practice of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
The University of Texas Health Science Center at Houston (UTHealth) has received funding through a public/private partnership for the first-ever clinical trial investigating a stem cell therapy for early treatment and prevention of complications after severe traumatic injury.
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many patients become resistant to treatment. A team at The University of Texas MD Anderson led a study which may explain how resistance evolves over time, and potentially which patients could benefit from chemotherapy.
Much to her relief, a patient at UTHealth in Houston was one of the first people in North America to undergo an experimental treatment option for people struggling with treatment-resistant depression (TRD).
A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation well before cancer development, according to research from The University of Texas MD Anderson Cancer Center. The preclinical research challenges traditional models of cancer immune activation and suggests immunotherapy may be useful for colorectal cancer prevention in certain high-risk groups.
Just like people, some T cells have excellent memories. These subtypes known as memory T cells may explain why some immunotherapies are more effective than others and potentially lead to researchers designing more effective studies using combination checkpoint blockade treatments, according to experts at The University of Texas MD Anderson Cancer Center.
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary and papillary thyroid, non-small cell lung, colorectal and bile duct cancers, which have been historically difficult to treat.
Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center offers a potential explanation for why the disease becomes chemoresistant, and a possible avenue to explore new diagnostic approaches.
Patients with cholangiocarcinoma, a form of liver cancer, were never candidates for liver transplant in the past. However, a new study looking at treating these patients with chemotherapy treatment first.
The Tiny Tot Clinic helps premature babies realize their full potential.
Houston Methodist Global Health Services is working with the Kingdom of Saudi Arabia and the Ministry of Health to decrease sepsis across the entire area.
A rare, inherited neurodegenerative disorder will soon be the focus of an international clinical research effort led by Houston Methodist and funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
Judith Smith, now 71, was at a routine appointment several years ago with her longtime ophthalmologist when the doctor made a comment that her right eye looked a little suspicious for glaucoma, an incurable disease that occurs when the optic nerve is damaged by pressure building inside the eye. Smith didn’t think she needed to worry about it since her doctor had just mentioned it in passing, so she put it out of her mind. A year later, when Smith returned for her checkup, her doctor was shocked to find that the optic nerve in her eye was already compromised and possibly permanently damaged.
Prominent health professionals will address students, faculty, staff and guests when the six schools of The University of Texas Health Science Center at Houston (UTHealth) hold their 2018 commencement ceremonies.
Surgeons at The University of Texas Health Science Center at Houston (UTHealth) are seeking community input for a proposed study into the effectiveness of a potential treatment for trauma-related abdominal bleeding.
Researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) have been awarded grants from the National Institutes of Health (NIH) to explore how the buildup of protein deposits in the brain can trigger dementia and stroke.
At the heart of any cancer diagnosis or treatment are cells. If one thinks of the cell components controlling gene activation as a Russian nesting-doll of gene regulatory layers, within those increasingly smaller tiers are short pieces of non-coding DNA called enhancers. A study at The University of Texas MD Anderson Cancer Center reveals enhancers as a significant area of research for diagnosing and/or treating many cancers.
Researchers from The University of Texas MD Anderson Cancer Center have found a startling amount of new information about molecular features of tumors as well as identified previously unknown cancer subtypes based on a comprehensive analysis of 2,579 tumors from breast and four different types of gynecologic cancers. These new findings potentially could serve as a launching pad for future therapeutic studies.
Four months after Hurricane Harvey soaked the Houston area and displaced more than a third of the population, an alarming 52 percent of Harris County residents said they were still struggling to recover, according to a new report from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.
The Hurricane Harvey Relief Fund has awarded $2.6 million to The University of Texas Health Science Center at Houston (UTHealth) for a technology-supported program for patients with unmet post-Harvey behavioral health needs.
Sinus surgeons with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center are the first in the United States to use augmented reality technology during minimally invasive sinus procedures.
UT Physicians has responded to a growing demand for specialty care with the opening of a new physical medicine, rehabilitation, sports medicine and pain management clinic in southwest Houston. The outpatient clinic provides patients with comprehensive, state-of-the-art care for joint pain, spine pain and sports-related injuries.
One of the nation’s leading cardiologists is challenging the new hypertension guidelines, perhaps sparing up to 10 million people from unnecessarily aggressive blood pressure treatments. His team’s study results appear March 7 in the Journal of the American College of Cardiology.
The University of Texas MD Anderson Cancer Center and Berkeley Lights, Inc. today announced the launch of Optera Therapeutics Corp, a biopharmaceutical company developing cell therapies with scalable manufacturing solutions for cancer.
A metal plate might be the cure for a common foot injury seen in athletes and people on their feet all day, according to new research conducted at Houston Methodist.
A powerful resistance mutation that appeared to emerge in melanoma after a patient received a targeted therapy combination, instead was lurking in the tumor all along, primed to thwart treatment before it began, researchers at The University of Texas MD Anderson Cancer Center report online at Cancer Discovery.
This year’s flu season has been one of the worst in recent memory causing thousands of people to be hospitalized. The virus can be particularly dangerous for young men who can experience nerve damage caused by the body’s response to the flu.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors, and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy (ART), which is currently only used at highly specialized care centers.
The new president of the Society for Maternal-Fetal Medicine (SMFM) is Sean Blackwell, M.D., professor and chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at McGovern Medical School at the University of Texas Health Science Center in Houston (UTHealth).
The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30 percent of the $73.5 million in awards CPRIT announced today. The awards included $16.3 million for individual investigator research including awards for cancer in children and adolescents, computational biology, clinical translation, and prevention and early detection. MD Anderson also received $2 million for recruitment and $4 million for a colorectal cancer prevention coalition award.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right